It is strictly prohibited for human consumption, and it is not meant for medical, veterinary, or household uses
Eggers and Beggs tests were applied to assess funnel plot symmetry quantitatively.29 We also used the CINeMA (Confidence in Network Meta-Analysis) framework to assess the certainty of the evidence in six key areas, including within-study bias, reporting bias, indirectness, imprecision, heterogeneity, and inconsistency.3031 We assessed intransitivity for the CINeMA framework by comparing potential effect modifiers, such as baseline age and HbA 1c concentration, between studies that provided direct and indirect evidence for each comparison
Research has definitively shown that people who experience GI side effects don't lose more weight than those who don't
For a broader look at how GLP-1 treatment changes hunger and digestion, our article on how GLP-1 medications help with weight loss is worth a look
Ultimately, a better understanding of the relationship between GBM, epilepsy, and SDs will stem from further experimental investigations
A 2022 systematic review and meta-analysis in JAMA Internal Medicine found increased rates of gallbladder or biliary disease among GLP-1 receptor agonist users compared to placebo or active comparators, with higher risk at weight-loss doses